Generation and characterization of interferon-lambda 1-resistant H1N1 influenza A viruses

• Natalia A. Ilyushina ,

  Roles Conceptualization, Formal analysis, Investigation, Project administration, Supervision, Writing – original draft, Writing – review & editing

  * E-mail: Natalia.Ilyushina@fda.hhs.gov (N.A. Ilyushina); Raymond.Donnelly@fda.hhs.gov (R.P. Donnelly)

  Affiliation Division of Biotechnology Research and Review II, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, United States of America

  http://orcid.org/0000-0001-8178-0472

  ⨯
• Vladimir Y. Lugovtsev,

  Roles Investigation, Resources

  Affiliation Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, United States of America

  ⨯
• Anastasia P. Samsonova,

  Roles Investigation

  Affiliation Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, United States of America

  ⨯
• Faruk G. Sheikh,

  Roles Investigation

  Affiliation Division of Biotechnology Research and Review II, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, United States of America

  ⨯
• Nicolai V. Bovin,

  Roles Resources

  Affiliation Carbohydrate Chemistry Laboratory, Shemyakin Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia

  ⨯
• Raymond P. Donnelly

  Roles Resources, Writing – review & editing

  * E-mail: Natalia.Ilyushina@fda.hhs.gov (N.A. Ilyushina); Raymond.Donnelly@fda.hhs.gov (R.P. Donnelly)

  Affiliation Division of Biotechnology Research and Review II, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, United States of America

  ⨯